acute respiratory distress syndrome

acute respiratory distress syndrome
Name	Acute respiratory distress syndrome
Field	Pulmonology, Critical care medicine
Symptoms	Shortness of breath, rapid breathing, low blood oxygen
Complications	Sepsis, Multiple organ dysfunction syndrome
Onset	Rapid
Causes	Sepsis, Pneumonia, Aspiration
Risks	Smoking, Alcoholism, Diabetes mellitus
Treatment	Mechanical ventilation, supportive care
Frequency	Common in intensive care units

acute respiratory distress syndrome

Acute respiratory distress syndrome is a severe, rapid-onset form of respiratory failure that requires urgent Intensive care medicine and advanced life support; it has been described in association with major events such as 1918 influenza pandemic, H1N1 influenza pandemic, and the COVID-19 pandemic. Clinically, it presents in patients from diverse settings including Trauma centers, Burn units, and wards treating Sepsis and Pneumonia, and is managed by teams from Anaesthesia and Pulmonology. Research into ARDS has been advanced by trials conducted at institutions such as National Institutes of Health, World Health Organization, and major academic centers like Johns Hopkins Hospital and Mayo Clinic.

Introduction

Acute respiratory distress syndrome (ARDS) was first characterized following outbreaks linked to World War II era observations and later formalized by seminal reports from investigators at Harvard Medical School and Massachusetts General Hospital; notable contributions came from clinicians associated with institutions including University of Pennsylvania and Columbia University Irving Medical Center. Its recognition reshaped care practices in Intensive care units and influenced guidelines from organizations such as the European Society of Intensive Care Medicine and the American Thoracic Society. Epidemiologic studies across regions — for example, registries in United Kingdom, United States, India, China, and Brazil — have documented variable incidence tied to local burdens of Sepsis and Pneumonia.

Signs and symptoms

Patients typically develop acute hypoxemia, great respiratory distress, and bilateral lung infiltrates on imaging; frontline clinicians from Emergency Medicine and Critical care medicine use tools developed at centers like Stanford Hospital and Cleveland Clinic to recognize deterioration. Common bedside findings prompt consultation with specialists from Radiology and Thoracic surgery and include tachypnea, refractory hypoxemia despite oxygen, and diffuse crackles similar to patterns seen in severe Pneumonia or chemical inhalation injuries described in literature from Tokyo and Los Angeles. Associated systemic signs often overlap with syndromes encountered by teams at Massachusetts General Hospital and Charité – Universitätsmedizin Berlin, including shock and organ dysfunction noted in cohorts from Paris and Seoul.

Causes and risk factors

Well-established precipitants include Sepsis, Pneumonia, Aspiration of gastric contents, and major Trauma such as that seen in patients from Iraq War and Afghanistan conflict casualty series; viral triggers have included pathogens implicated in the 2009 H1N1 pandemic and the COVID-19 pandemic. Risk is increased by comorbidities commonly managed at centers like Mayo Clinic and Johns Hopkins Hospital—for example, chronic alcohol use disorders noted at Veterans Affairs hospitals, chronic Diabetes mellitus, and chronic liver disease described in cohorts from University of California, San Francisco. Iatrogenic contributors arise from transfusion practices reviewed by panels at American Association of Blood Banks and perioperative events encountered in Cardiac surgery units at Cleveland Clinic and Mount Sinai Hospital.

Pathophysiology

Pathophysiology involves diffuse alveolar damage, capillary endothelial injury, and loss of alveolar epithelial integrity leading to protein-rich pulmonary edema; mechanistic insights have been advanced by basic science programs at National Institutes of Health, Wellcome Trust, and research centers like Broad Institute and Salk Institute. Inflammatory cascades implicating neutrophils, cytokines, and complement were characterized in studies from University of Pennsylvania and University of Chicago, with parallel work on ventilator-induced lung injury emerging from Harvard Medical School and Imperial College London. Microvascular thrombosis described during the COVID-19 pandemic linked ARDS to coagulation pathways studied at Karolinska Institutet and The Rockefeller University.

Diagnosis

Diagnosis combines clinical criteria, arterial blood gas analysis, and imaging modalities including chest radiography and computed tomography performed in radiology departments at Mayo Clinic and University College London Hospitals; diagnostic frameworks were standardized by consensus panels such as the Berlin Definition working group and professional societies including the American Thoracic Society. Differential diagnosis often requires exclusion of cardiogenic pulmonary edema, pulmonary embolism, and diffuse alveolar hemorrhage—conditions evaluated by cardiology teams at Mount Sinai Hospital and vascular medicine services at Cleveland Clinic. Biomarker research from institutions like Stanford University and Massachusetts General Hospital explores plasma proteins and genetic signatures to refine early detection.

Management and treatment

Supportive intensive care is cornerstone treatment, employing lung-protective ventilation strategies developed from landmark trials at ARMA trial collaborators and implemented broadly in Intensive care units across United States, Europe, and Australia. Adjunctive therapies include prone positioning validated in multicenter trials coordinated by groups at Erasmus MC and Vall d'Hebron University Hospital, neuromuscular blockade applied per protocols from French National Institute for Health and Medical Research, and extracorporeal membrane oxygenation provided by referral centers such as Cleveland Clinic and Papworth Hospital. Pharmacologic interventions remain limited; investigational approaches have been tested in trials supported by National Institutes of Health, Wellcome Trust, and academic consortia at Oxford University and Harvard Medical School.

Prognosis and complications

Prognosis varies with severity, age, and comorbidities; historical cohorts from ICU registries at Johns Hopkins Hospital, Karolinska University Hospital, and Addenbrooke's Hospital report substantial short-term mortality and long-term morbidity including pulmonary fibrosis, physical disability, and cognitive impairment similar to outcomes documented in survivors of Sepsis and Trauma. Complications encompass ventilator-associated pneumonia, barotrauma, and multiple organ dysfunction syndrome as described in clinical reviews from European Respiratory Society and Society of Critical Care Medicine. Long-term follow-up programs established at centers such as Mayo Clinic and University of Toronto aim to address rehabilitation and quality-of-life issues in survivors.

Category:Respiratory diseases